DK1330442T3 - Phthalazinone derivatives - Google Patents

Phthalazinone derivatives

Info

Publication number
DK1330442T3
DK1330442T3 DK01976521.3T DK01976521T DK1330442T3 DK 1330442 T3 DK1330442 T3 DK 1330442T3 DK 01976521 T DK01976521 T DK 01976521T DK 1330442 T3 DK1330442 T3 DK 1330442T3
Authority
DK
Denmark
Prior art keywords
phthalazinone derivatives
phthalazinone
derivatives
Prior art date
Application number
DK01976521.3T
Other languages
Danish (da)
Inventor
Niall Morrison B Martin
Graeme Cameron M Smith
Roger Frank Newton
Diane Gillian Douglas
Penny Jane Eversley
Julia Vile
Charles Richard White
Original Assignee
Kudos Pharm Ltd
Maybridge Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kudos Pharm Ltd, Maybridge Ltd filed Critical Kudos Pharm Ltd
Priority claimed from PCT/GB2001/004729 external-priority patent/WO2002036576A1/en
Application granted granted Critical
Publication of DK1330442T3 publication Critical patent/DK1330442T3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50Pyridazines; Hydrogenated pyridazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50Pyridazines; Hydrogenated pyridazines
    • A61K31/502Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with carbocyclic ring systems, e.g. cinnoline, phthalazine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30Phthalazines
    • C07D237/32Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK01976521.3T 2000-10-30 2001-10-25 Phthalazinone derivatives DK1330442T3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0026505.8A GB0026505D0 (en) 2000-10-30 2000-10-30 Phthalazinone derivatives
US27506601P 2001-03-12 2001-03-12
PCT/GB2001/004729 WO2002036576A1 (en) 2000-10-30 2001-10-25 Phthalazinone derivatives

Publications (1)

Publication Number Publication Date
DK1330442T3 true DK1330442T3 (en) 2011-04-11

Family

ID=9902199

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01976521.3T DK1330442T3 (en) 2000-10-30 2001-10-25 Phthalazinone derivatives

Country Status (8)

Country Link
JP (1) JP4903355B2 (en)
AT (1) ATE496034T1 (en)
DE (1) DE60143905D1 (en)
DK (1) DK1330442T3 (en)
ES (1) ES2359131T3 (en)
GB (1) GB0026505D0 (en)
PT (1) PT1330442E (en)
ZA (1) ZA200302112B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001295789B2 (en) * 2000-10-30 2006-05-11 Kudos Pharmaceuticals Ltd Phthalazinone derivatives
KR20070057859A (en) * 2004-08-26 2007-06-07 쿠도스 파마슈티칼스 리미티드 4-heteroarylmethyl substituted phthalazinone derivatives
GB0428111D0 (en) * 2004-12-22 2005-01-26 Kudos Pharm Ltd Pthalazinone derivatives
RS53196B (en) * 2006-12-28 2014-06-30 Abbvie Inc. Inhibitors of poly(adp-ribose) polymerase
WO2012014221A1 (en) * 2010-07-27 2012-02-02 Cadila Healthcare Limited Substituted 4-(4-fluoro-3-(piperazine-1- carbonyl)benzyl)phthalazin-1(2h)-one derivatives as poly (adp-ribose) polymerase- 1 inhibitors
CN103130723B (en) 2011-11-30 2015-01-14 成都地奥制药集团有限公司 Poly (aenosine diphosphate glucose pyrophospheralase (ADP)-ribose) polymerase inhibitor
JP6545148B2 (en) * 2013-03-13 2019-07-17 フラットリー ディスカバリー ラブ,エルエルシー Pyridazinone compounds and methods for the treatment of cystic fibrosis

Also Published As

Publication number Publication date
ES2359131T3 (en) 2011-05-18
JP2004513121A (en) 2004-04-30
JP4903355B2 (en) 2012-03-28
GB0026505D0 (en) 2000-12-13
PT1330442E (en) 2011-04-20
DE60143905D1 (en) 2011-03-03
ATE496034T1 (en) 2011-02-15
ZA200302112B (en) 2004-02-20

Similar Documents

Publication Publication Date Title
DK1292604T3 (en) 2-aminocarbonyl-9H-purine derivatives
EE200300071A (en) Quinazoline derivatives
DE60134338D1 (en) PIPERAZIN DERIVATIVES
ATE288437T1 (en) TETRAHYDRO-HETEROCYCLOAZEPINYL-PYRIMIDINE DERIVATIVES E
ATE263748T1 (en) ADMANTANE DERIVATIVES
ATE298332T1 (en) DECAHYDRO-ISOCHINOLINE DERIVATIVES
ATE293104T1 (en) THIAZOLYLAMIDE DERIVATIVES
DK1280809T3 (en) Antitumorecteinascidin derivatives
ATE257148T1 (en) PROPARGYLETHER DERIVATIVES
DE50114491D1 (en) Substituted C-cyclohexylmethylamine derivatives
ATE374747T1 (en) MONOFLUORALKYL DERIVATIVES
ATE273272T1 (en) MEVINOLINE DERIVATIVES
AR028602A1 (en) PIRROL DERIVATIVES
AR028282A1 (en) AMINOFENIL PIRIMIDONA DERIVATIVES
ATE254598T1 (en) 4-HYDROXYBIPHENYLHYDRAZIDE DERIVATIVES
ATE293592T1 (en) RESOCINE DERIVATIVES
DK1322593T3 (en) O-substituted-6-methyl-tramadol derivatives
ATE282021T1 (en) SUBSTITUTED AMINOMETHYL-PHENYL-CYCLOHEXANE DERIVATIVES
PT1351959E (en) NEW PLEUROMUTILINE DERIVATIVES
DK1246791T3 (en) Aminomethyl-phenyl-cyclohexanone derivatives
DK1330442T3 (en) Phthalazinone derivatives
ATE361274T1 (en) SUBSTITUTED 5-AMINO-1-PENTENE-3-OL DERIVATIVES
ATE269328T1 (en) 1-CYCLOALKYLPYRAZOLYL-BENZOYL DERIVATIVES
ATE374776T1 (en) PYRROLOTRIAZOLOPYRIMIDINONE DERIVATIVES
NO20024393D0 (en) 2-sulphonylphenyl-4-one derivatives